全文获取类型
收费全文 | 262篇 |
免费 | 31篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 10篇 |
妇产科学 | 1篇 |
基础医学 | 30篇 |
口腔科学 | 3篇 |
临床医学 | 47篇 |
内科学 | 32篇 |
皮肤病学 | 2篇 |
神经病学 | 29篇 |
特种医学 | 50篇 |
外科学 | 42篇 |
综合类 | 20篇 |
预防医学 | 11篇 |
眼科学 | 2篇 |
药学 | 37篇 |
中国医学 | 1篇 |
肿瘤学 | 23篇 |
出版年
2022年 | 1篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 5篇 |
2015年 | 6篇 |
2014年 | 4篇 |
2013年 | 11篇 |
2012年 | 4篇 |
2011年 | 3篇 |
2010年 | 7篇 |
2009年 | 7篇 |
2008年 | 3篇 |
2007年 | 33篇 |
2006年 | 5篇 |
2005年 | 14篇 |
2004年 | 2篇 |
2003年 | 6篇 |
2002年 | 4篇 |
2001年 | 8篇 |
2000年 | 6篇 |
1999年 | 8篇 |
1998年 | 13篇 |
1997年 | 10篇 |
1996年 | 15篇 |
1995年 | 10篇 |
1994年 | 7篇 |
1993年 | 16篇 |
1992年 | 7篇 |
1991年 | 13篇 |
1990年 | 15篇 |
1989年 | 16篇 |
1988年 | 14篇 |
1987年 | 11篇 |
1986年 | 6篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1973年 | 1篇 |
1972年 | 2篇 |
排序方式: 共有341条查询结果,搜索用时 15 毫秒
41.
Frozen sections from 28 pituitary adenomas were reached with a panel of monoclonal antibodies to macrophages, lymphocytes and HLA-Dr invariant chain. A low number of macrophages were demonstrated in all tumors, mainly perivascular. CD8 and CD4 lymphocytes were detected in even smaller numbers in 80% and 14% of tumors respectively. B lymphocytes were present in only 1 case. An occasional NK cell was present in 1/13 cases studied. HLA-Dr antigen was expressed by macrophages in all cases and by tumor cells in 2 growth hormone-producing adenomas/19 adenomas. These findings may represent evidence for a low degree of cellular immune response to pituitary adenomas. 相似文献
42.
Cloning, functional activities and in vivo tissue distribution of rat NKR-P1+ TCR alpha beta + cells
Knudsen E; Seierstad T; Vaage JT; Naper C; Benestad HB; Rolstad B; Maghazachi AA 《International immunology》1997,9(7):1043-1051
We have successfully cloned nine NKR-P1+ TCR alpha beta + cells from PVG
rat spleens, utilizing murine macrophage inflammatory protein-1 alpha
(MIP-1 alpha) and IL-2. These clones are either double negative (DN,
CD4-CD8-), which included clones 3.31, 3.71, 4.19, 4.59 and 4.65, or single
positive (SP, CD4+CD8-), which included clones 1.64, 3.8, 3.76 and 3.78. No
CD8+ clone was recovered. All nine clones are restricted in terms of their
expression of the V beta antigens, since they express V beta 8.2 but not V
beta 8.5, V beta 10 or V beta 16. These clones are agranular and they fall
to generate NK or LAK activity upon incubation with IL-2, IL-12 or their
combination. On the basis of their production of intracellular cytokines
they can be divided into three categories: (I) SP clones (1.64, 3.8, 3.76
and 3.78) do not produce IL-2 or IL-4, but produce IFN-gamma and IL-12, and
they vary in their production of IL-1, RANTES or tumor necrosis factor
(TNF)-alpha; (II) DN clones 4.59 and 4.65 produce IL-1 alpha and IFN-gamma
only, and fall to produce other cytokines; and (III) DN clones 3.31, 3.71
and 4.19 produce IL-1 alpha, IL-1 beta, IL-2, IL-12, IFN-gamma, RANTES and
TNF-alpha. From all the clones examined only DN clones 3.31 and to a lesser
degree 4.19 produce IL-4. In vivo tissue localization of clones 3.8, 3.31
and 4.59 shows that these cells distribute into the liver and bone marrow
24 h post i.v. administration. Their accumulation in the liver and bone
marrow along with their ability to secrete various cytokines suggest that
these cells may influence the generation, differentiation or apoptosis of
immune or hematopoietic cells.
相似文献
43.
O Godon H Fontaine S Kahi JF Meritet D Scott-Algara S Pol ML Michel M Bourgine ; for the ANRS HB study group 《Molecular therapy》2014,22(3):675-684
A substudy of a phase I/II, prospective, multicenter clinical trial was carried out to investigate the potential benefit of therapeutic vaccination on hepatitis B e antigen-negative patients with chronic hepatitis B (CHB), treated efficiently with analogues. Patients were randomized in 2 arms, one receiving a hepatitis B virus (HBV) envelope DNA vaccine, and one without vaccination. At baseline, HBV-specific interferon (IFN)-γ–producing T cells were detected in both groups after in vitro expansion of peripheral blood mononuclear cells. Vaccine-specific responses remained stable in the vaccine group, whereas in the control group the percentage of patients with HBV-specific IFN-γ–producing T cells decreased over time. The vaccine-specific cytokine-producing T cells were mostly polyfunctional CD4+ T cells, and the proportion of triple cytokine-producer T cells was boosted after DNA injections. However, these T-cell responses did not impact on HBV reactivation after stopping analogue treatment. Importantly, before cessation of treatment serum hepatitis B surface antigen (HBsAg) titers were significantly associated with DNA or HBsAg clearance. Therapeutic vaccination in CHB patients with persistent suppression of HBV replication led to the persistence of T-cell responses, but further improvements should be searched for to control infection after treatment discontinuation. 相似文献
44.
45.
商陆多糖Ⅱ体外对小鼠脾细胞增殖及产生集落刺激因子的影响 总被引:10,自引:0,他引:10
用[3H]TdR参入法检测小鼠脾细胞增殖能力及产生集落刺激因子(colony stimulating factor. CSF)含量.证明商陆多糖Ⅱ(PAP-Ⅱ)在31~500 μg·m-1范围内显著促进小鼠稗细胞增殖。PAP-Ⅱ,31~125 μg·ml-1可剂量依赖性地促进Con A(1,2.8μg·ml-1),LPS(3,10,30 μg·ml-1)诱导的淋巴细胞细咆增殖,随着PAP-Ⅱ剂量加大,对丝裂原诱导的淋巴细胞增殖反呈抑制作用。PAP-Ⅱ。10~500μg·ml-1呈剂量及时间依赖性地促进脾细胞产生CSF,其最适剂量为100 μg·ml-1。最佳时间为5 d,提示PAP-Ⅱ能增强免疫及促进造血功能。 相似文献
46.
47.
48.
间硝苯地平对血管紧张素Ⅱ促进血管平滑肌细胞增殖和蛋白质合成的影响 总被引:1,自引:0,他引:1
以培养血管平滑肌细胞(vascularsmcothmusclecell,VSMC)为模型,观察了间硝苯地平(m-nifedipine,m-Nif)对血管紧张素Ⅱ(angiotensinⅡ,ANGⅡ)促进VSMC增殖和蛋白质合成的影响。结果表明,m-Nif抑制ANGⅡ(100nmol·L ̄(-1))引起VSMC[ ̄3H]thymidine和[ ̄3H]leucine参入,并呈剂量依赖性。m-Nif(2×10 ̄(-6)mol·L ̄(-1))可抑制ANGⅡ对VSMC的刺激、DNA及蛋白质合成速率,分别降低了46%,58%,53%。提示m-Nif可抑制ANGⅡ对VSMC增殖和蛋白合成的促进作用 相似文献
49.
50.